Feeling mild COVID-19 symptoms? For the safety of our community, you do NOT need to visit the emergency department unless critical symptoms are experienced. Visit our COVID-19 hub to learn more.Visit the COVID-19 Hub
Executive Director, TGH Transplant Institute
Surgical Director, Center for Advanced Liver Disease and Transplant, TGH Transplant Institute
Kiran Dhanireddy, MD, serves as the executive director of the TGH Transplant Institute as well as the surgical director of the Center for Advanced Liver Disease and Transplant, and TGH Transplant Institute. Board certified in general surgery, he earned his medical degree from Georgetown University School of Medicine in Washington, D.C., and completed a general surgery residency at Georgetown University Medical Center, a research fellowship at the National Institutes of Health (NIH) and a fellowship in liver transplantation and hepatobiliary surgery at UCLA. Dr. Dhanireddy has served in academic, clinical and administrative appointments, including chief of service for hepatopancreaticobiliary surgery at LA County + USC, director of pancreas transplantation at University of Southern California (USC), director of quality at the USC Transplant Institute and chief medical officer at the USC Care Medical Group.
Dr. Dhanireddy’s clinical interests include liver transplantation, live donor liver transplantation, partial liver transplantation, and surgical management of liver, gallbladder biliary tract and pancreatic diseases. His research areas of interest include liver transplant organ allocation, disparities in access to organ transplantation, and transplant tolerance.
Medical Director, Center for Advanced Liver Disease and Transplant
Nyingi Kemmer, MD, MPH, MSc, is a transplant hepatologist with Tampa General Medical Group. Dr. Kemmer completed her medical degree at the University of Sokoto in Sokoto, Nigeria, and residency at Cook County Hospital in Chicago, Ill. She went on to complete a gastroenterology fellowship at the University of Texas Medical Group in Galveston, Texas, and transplant hepatology fellowship training at the Scripps Clinic in La Jolla, Calif.
Dr. Kemmer is actively involved in clinical research and completed a Master of Public Health with a focus in outcomes research and a Master of Science in drug development and pharmacogenomics. Her research interest is in health-related quality of life, clinical outcomes and disparities in liver transplantation. Her research pertaining to transplant immunosuppression, clinical outcomes and disparities in liver transplantation has been published in numerous journals.